Drug Evaluation Committee Presentation materials for "Workshop on Pediatric Drug Development" held on March 29, 2022 are available.
Clinical Evaluation Subcommittee
Materials from the "Workshop on Pediatric Drug Development" held on March 29, 2022 are now available.
While there is a high demand for pediatric drug development, various issues must be resolved in order to promote it. In this workshop, task force members of the Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee will discuss two issues (1) Patient Centricity and (2) Pharmacometrics for pediatric drug development, together with doctors who are active at the forefront of pediatric drug development in academia. The workshop was held to exchange opinions focusing on two issues: 1) Patient Centricity, and 2) solving technical issues by using pharmacometrics. We hope that this workshop will serve as an opportunity to further promote pediatric drug development.
Workshop on Pediatric Drug Development" held on the web on March 29, 2022